The indolent natural history of essential thrombocythemia: a challenge to new drug development.
Tefferi
Ayalew
A
Department of Internal Medicine and Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA. tefferi.ayalew@mayo.edu
D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use; D013920:Thrombocythemia, Essential / Q000188:drug therapy*
D006918:Hydroxyurea